At a glance
- Originator Roche Palo Alto LLC
- Class Antimigraines; Pyrimidines; Small molecules
- Mechanism of Action Serotonin 2B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 09 Nov 2006 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
- 21 Sep 1999 New profile
- 21 Sep 1999 Preclinical development for Anxiety disorders in USA (Unknown route)